AtlasSalivaryMucoepidermoid Carcinoma

Salivary Gland Disorders

Mucoepidermoid Carcinoma

aka MEC

The most common malignant salivary gland tumour; composed of mucous, intermediate and epidermoid cells with CRTC1/MAML2 fusion driving pathogenesis.

Genetics
CRTC1-MAML2
Site
Parotid & palate
Rx
Excision + risk-based RT

§ overviewOverview

Malignant epithelial salivary gland neoplasm characterised by variable proportions of mucous, intermediate and squamoid cells.

§ icdICD Classification

C07/C08

§ etiologyEtiology

  • 01Sporadic; ionising radiation increases risk
  • 02CRTC1(MECT1)-MAML2 fusion in ≈50–70%

§ epidemiologyEpidemiology

≈30% of salivary malignancies; parotid > minor glands (palate); commonest salivary malignancy in children.

§ clinicalClinical Features

  • 01Painless slow-growing swelling (low grade) — may mimic mucocele on palate
  • 02Rapidly growing painful mass with fixation, facial nerve palsy (high grade)
  • 03Fluctuant bluish palatal swelling common

§ differentialDifferential Diagnosis

  • 01Pleomorphic adenoma
  • 02Mucocele (minor glands)
  • 03Adenoid cystic carcinoma
  • 04SCC

§ histopathHistopathology

  • 01Mixture of mucous (goblet), intermediate and epidermoid cells
  • 02Cystic spaces (low grade) → solid sheets with atypia (high grade)
  • 03Mucicarmine and PAS-diastase stain mucous cells

§ investigationsInvestigations

  • 01MRI (soft-tissue detail, perineural spread)
  • 02FNAC / core biopsy
  • 03CT chest for staging

§ ihcIHC / Special Stains

  • 01CK7+, p63 in epidermoid cells
  • 02MAML2 FISH for confirmation

§ classificationClassification

  • 01Grading systems: AFIP, Brandwein, MSK — based on cystic component, invasion, necrosis, mitoses, perineural spread
  • 02Low, intermediate, high grade

§ treatmentTreatment

  • 01Wide local excision with clear margins
  • 02Parotid: superficial or total parotidectomy with facial nerve preservation
  • 03Neck dissection for high-grade / cN+
  • 04Adjuvant radiotherapy for high-grade, positive margins, perineural or vascular invasion
  • 05Chemotherapy for palliation

§ complicationsComplications

  • 01Facial nerve injury
  • 02Recurrence (high grade)
  • 03Distant metastases (lung, bone) in high-grade

§ prognosisPrognosis

5-year survival: low grade >90%, intermediate ~70%, high grade 30–50%.

§ examKey Examination Points

  • 01Bluish palatal swelling in adult → not a mucocele until proven otherwise
  • 02Always image before biopsy of parotid mass

§ revisionQuick Revision Summary

  • 01MAML2 fusion · commonest paediatric salivary malignancy · grade determines prognosis

§ vivaBDS Viva Questions

  • 01Diagnostic translocation of MEC?
  • 02Grading criteria?
  • 03Approach to parotid MEC?

§ mcqsMCQs — Assessment (3)

Question 1

Most common malignant salivary gland tumour:

Question 2

Characteristic gene fusion:

Question 3

Commonest intraoral site:

References

  1. WHO Head & Neck Tumours 2022

Draft — pending faculty review. Educational use only; verify against current guidelines and primary sources before clinical application.